课题基金 / 基金详情

Training Program/Rheumatic Diseases

Training Program/Rheumatic Diseases
培训项目/风湿病
批准号:
10375474
负责人:
EDWARD M BEHRENS
金额:
$35.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-01 至 2025-04-30

项目摘要

项目成果

EDWARD M BEHRENS的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 风湿性疾病培训计划已经有三十年的历史,提供尖端培训 医生和科学家在调查的病理生理学,诊断,治疗,和结果, 风湿性疾病该计划是成人和儿科部门之间的合作努力, 沿着的是宾夕法尼亚大学和费城儿童医院的流变学 宾夕法尼亚大学生物医学研究生课程,医学科学家培训计划,以及 成人和儿科流变学分部的研究生医学教育计划。程序 提供了丰富多样的指导环境,用于基础实验室调查,转化研究, 临床流行病学和生物信息学,并跨越免疫学,肌肉和骨骼生物学和临床 流变学知识领域。我们的多学科培训师队伍来自医学院, 兽医学院、牙科学院、艺术与科学学院和Wistar研究所,并代表 多个部门和部门。要求培训3个博士前和3个博士后职位。预处理 博士生是从宾夕法尼亚大学竞争激烈的博士生中招募的 生物医学研究生课程的MD/PhD课程,并且必须完成严格的教学课程, 以及论文评审委员会的认真评审。博士后培训生是从已经很高的 来自成人和儿童流变学研究金的有竞争力的精选临床研究员 项目以及参与学校的博士科学家调查风湿病的各个方面。 一般的任用期为2年,等待受训者取得适当的进展。所有学员都可从 强大的环境座谈会,研讨会,务虚会和讲座,并预计将有助于这种环境 通过他们自己的演讲和出版物。学员将使用个性化发展评估 由培训生、导师和本计划的PI审核的计划。该方案本身不断 通过内部咨询委员会的年度审查,根据受训人员和导师的直接反馈进行评估 和外部顾问,并通过自学技巧。作为成功的衡量标准,该计划 成功地培训了一些研究人员,他们现在正在进行自己独立的NIH资助的研究 在风湿性疾病的项目从两个前和博士后培训流。在承认快速 技术和方法的扩展,允许模糊实验室和临床之间的界限 研究,该计划特别强调在生物信息学方面培养导师和学员, 翻译科学,和其他领域,以定位自己继续我们的成功, 培养未来风湿病科学研究的领导者。
英文摘要
Project Summary The Training Program in Rheumatic Diseases has had a three-decade history of providing cutting edge training physicians and scientists in the investigation of the pathophysiology, diagnosis, treatment, and outcomes of rheumatic diseases. The Program is a collaborative effort between the Adult and Pediatric Divisions of Rheumatology at The University Pennsylvania and The Children’s Hospital of Philadelphia along with The University of Pennsylvania Biomedical Graduate Studies program, the Medical Scientist Training Program, and the Graduate Medical Education programs of the Adult and Pediatric Rheumatology Divisions. The Program offers a rich and diverse mentored environment for training in basic lab investigation, translational research, clinical epidemiology, and bioinformatics and spans Immunology, Muscle and Bone Biology, and Clinical Rheumatology knowledge domains. Our multi-disciplinary cohort of trainers come from the School of Medicine, the Veterinary School, the Dental School, the School of Arts and Sciences, and the Wistar Institute and represent multiple Departments and Divisions. Training is requested for 3 pre-doctoral and 3 post-doctoral positions. Pre- doctoral trainees are recruited from students enrolled in The University of Pennsylvania’s highly competitive PhD and MD/PhD programs in Biomedical Graduate Studies, and must complete rigorous didactic coursework as well as careful thesis committee evaluation. Post-doctoral trainees are selected from the already highly competitive and select pool of clinical fellows from both the Adult and Pediatric Rheumatology fellowship programs as well as PhD scientists within the participating Schools investigating aspects of Rheumatic Disease. Typical appointments are for 2 years, pending appropriate progress by the trainee. All trainees benefit from a robust environment of colloquia, seminars, retreats, and lectures, and expected to contribute to this environment through their own presentations and publications. Trainees are assessed using an Individualized Development Plan that is reviewed by the trainee, mentor, and the PIs of this Program. The Program itself is continuously evaluated by direct feedback from trainees and mentors, through annual review by an Internal Advisory Board and an external consultant, and by self-study techniques. As a measure of success, this Program has successfully trained a number of investigators now running their own independent NIH funded research programs in Rheumatic Disease from both the pre- and post-doctoral training streams. In recognition of the rapid expansion of technology and methodology that allows for the blurring of lines between bench and clinical research, the Program has made particular emphasis in growing mentors and trainees in bioinformatics, translational science, and other domains in order to position ourselves to continue our success in the development of the future leaders of scientific inquiry into Rheumatic Disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training Program/Rheumatic Diseases
  • 批准号:
    10614409
  • 项目类别:
  • 资助金额:
    $34.68万
  • 财政年份:
    2020
  • 负责人:
    EDWARD M BEHRENS
  • 依托单位:
IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes
  • 批准号:
    9175786
  • 项目类别:
  • 资助金额:
    $64.31万
  • 财政年份:
    2016
  • 负责人:
    EDWARD M BEHRENS
  • 依托单位:
IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes
  • 批准号:
    9291411
  • 项目类别:
  • 资助金额:
    $59.85万
  • 财政年份:
    2016
  • 负责人:
    EDWARD M BEHRENS
  • 依托单位:
IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes
  • 批准号:
    9926221
  • 项目类别:
  • 资助金额:
    $58.67万
  • 财政年份:
    2016
  • 负责人:
    EDWARD M BEHRENS
  • 依托单位:
海外基金